BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11799174)

  • 1. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection.
    Yenigün A; Durupinar B
    J Virol; 2002 Feb; 76(4):1787-9. PubMed ID: 11799174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.
    Zavaglia C; Martinetti M; Silini E; Bottelli R; Daielli C; Asti M; Airoldi A; Salvaneschi L; Mondelli MU; Ideo G
    J Hepatol; 1998 Jan; 28(1):1-7. PubMed ID: 9537846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.
    Corghi DB; Gonçales NS; Marques SB; Gonçales FL
    Braz J Med Biol Res; 2008 Oct; 41(10):884-9. PubMed ID: 18925312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland.
    Wawrzynowicz-Syczewska M; Underhill JA; Clare MA; Boron-Kaczmarska A; McFarlane IG; Donaldson PT
    Liver; 2000 Jun; 20(3):234-9. PubMed ID: 10902974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.
    Cramp ME; Carucci P; Underhill J; Naoumov NV; Williams R; Donaldson PT
    J Hepatol; 1998 Aug; 29(2):207-13. PubMed ID: 9722201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
    Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
    J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin.
    Barrett S; Ryan E; Crowe J
    J Hepatol; 1999 Jun; 30(6):979-83. PubMed ID: 10406173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II.
    Ksiaa L; Ayed-Jendoubi S; Sfar I; Gorgi Y; Najjar HA; Abdallah TB; Ayed K
    Viral Immunol; 2007; 20(2):312-9. PubMed ID: 17603847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II alleles and chronic hepatitis C virus infection.
    Cangussu LOF; Teixeira R; Campos EF; Rampim GF; Mingoti SA; Martins-Filho OA; Gerbase-DeLima M
    Scand J Immunol; 2011 Sep; 74(3):282-287. PubMed ID: 21535077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.
    Lechmann M; Schneider EM; Giers G; Kaiser R; Dumoulin FL; Sauerbruch T; Spengler U
    Eur J Clin Invest; 1999 Apr; 29(4):337-43. PubMed ID: 10231346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients.
    Dinçer D; Besisik F; Oğuz F; Sever MS; Kaymakoglu S; Cakaloglu Y; Demir K; Türkoglu S; Carin M; Okten A
    Int J Artif Organs; 2001 Apr; 24(4):212-4. PubMed ID: 11394702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of hepatitis C virus infection under host factor influence in an ethnically complex population.
    Cursino-Santos JR; Donadi EA; Martinelli AL; Louzada-Junior P; Martinez-Rossi NM
    Liver Int; 2007 Dec; 27(10):1371-8. PubMed ID: 18036100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C.
    Jiao J; Wang JB
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):80-3. PubMed ID: 15730926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance.
    Spada E; Mele A; Berton A; Ruggeri L; Ferrigno L; Garbuglia AR; Perrone MP; Girelli G; Del Porto P; Piccolella E; Mondelli MU; Amoroso P; Cortese R; Nicosia A; Vitelli A; Folgori A
    Gut; 2004 Nov; 53(11):1673-81. PubMed ID: 15479691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Class II-DRB1 Alleles with Hepatitis C Virus Infection Outcome in Egypt: A Multicentre Family-based Study.
    El-Bendary M; Neamatallah M; Elalfy H; Besheer T; Kamel E; Mousa H; Eladl AH; El-Setouhy M; El-Gilany AH; El-Waseef A; Esmat G
    Ann Hepatol; 2019; 18(1):68-77. PubMed ID: 31113612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.
    McKiernan SM; Hagan R; Curry M; McDonald GS; Kelly A; Nolan N; Walsh A; Hegarty J; Lawlor E; Kelleher D
    Hepatology; 2004 Jul; 40(1):108-14. PubMed ID: 15239092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.
    Höhler T; Gerken G; Notghi A; Lubjuhn R; Taheri H; Protzer U; Löhr HF; Schneider PM; Meyer zum Büschenfelde KH; Rittner C
    J Hepatol; 1997 Mar; 26(3):503-7. PubMed ID: 9075656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
    El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
    Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.
    Jiang YG; Wang YM; Liu TH; Liu J
    World J Gastroenterol; 2003 Oct; 9(10):2221-5. PubMed ID: 14562382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection.
    Alric L; Izopet J; Fort M; Vinel JP; Fontenelle P; Orfila C; Payen JL; Sandres K; Desmorat H; Charlet JP; Duffaut M; Abbal M
    Hum Immunol; 1999 Jun; 60(6):516-23. PubMed ID: 10408801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.